MORE►
Series B
Qsic Co-Founder and CEO Matt Elsley [Composite photo; original: LinkedIn]
Qsic Snags $25M in Series B Funding to ‘Reinvent’ In‑Store Retail Audio
by Lance Murray | Jan 28, 2025
Qsic recently announced a partnership with Irving-based 7-Eleven to roll out "Gulp Radio" in 12,000 stores by the end of 2025. The Australian company has an office in Dallas, where its co-founder and CEO is leading Qsic's North America business growth.
by Lance Murray |
May 7, 2024
The Taiwanese cybersecurity company, whose U.S. HQ is in Irving, said that in addition to TGVest Capital—the lead investor of its B round—Pegatron Group, CDIB Capital Group, and CDIB-Innolux II LP are continuing to invest. New investors include the Taiwania Capital and Applied Ventures ITIC Innovation Fund LP, a joint fund of Applied Ventures, LLC and ITIC-Taiwan
MORE►
by Lance Murray |
May 25, 2023
Sera—a SaaS service for small-to-large size HVAC, plumbing, and other field service businesses—said it closed the oversubscribed funding round with a market cap three times the value the company had at the close of its Series A round in November 2021.
MORE►
by Lance Murray |
Dec 1, 2022
Stellar's platform leverages AI and machine learning to reimagine home maintenance. The startup partners with property managers and contractors to take care of homes and people—with a "mission of delivering hassle-free maintenance done right."
"We have caught lightning in a bottle," Founder and CEO Dustin Marx said of the new raise.
"We have caught lightning in a bottle," Founder and CEO Dustin Marx said of the new raise.
MORE►
Left to right: Dr. Shehnaaz Suliman, CEO and board member of ReCode; and David Lockhart, president and chief science officer. [Photos: Jennifer Leahy]
Dallas-Founded Biopharma Firm Raises $120M to Expand its Pipeline
by Kevin Cummings | Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases.
With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE►
by Alex Edwards |
Oct 21, 2021
The funding, which was co-led by Pfizer Ventures and EcoR1 Capital, will help drive ReCode's therapy programs for primary ciliary dyskinesia and cystic fibrosis into human clinical studies.
MORE►
by Alex Edwards |
Jul 29, 2021
On the heels of its launch in the multifamily proptech and funeral home industries, OneDay is accelerating its footprint with an influx of capital that will go to new hires, market expansion, and continued tech development.
MORE►
Supply Chain and Logistics Startup Slync.io Closes a $60M Series B Round Led by Goldman Sachs Growth
by Alex Edwards |
Feb 4, 2021
Slync.io, which offers process automation for enterprise supply chains and the global logistics industry, moved its headquarters to Dallas from California last year.
MORE►
Cellwize Secures $32M Series B Financing Led by Intel Capital and Qualcomm Ventures [Photo: Cellwize]
Cellwize Closes $32M Series B Round To Bring in the Age of 5G
by Alex Edwards | Nov 9, 2020
Cellwize, which has operations in Israel, Dallas, and Singapore, is behind a cloud-native platform that helps operators deploy 5G networks in a more efficient, scalable, and flexible way.
MORE►
by Lance Murray |
Mar 19, 2020
In this weekly roundup of funding, merger, and acquisition acitivity involving companies in North Texas, you'll also find news from StackPath, MedProperties, Naya Ventures, and Charter Health Care Group.
MORE►
by Lance Murray |
Mar 17, 2020
The new funding will be used to accelerate StackPatch's burgeoning product development, engineering, and go-to-market activities. StackPath is a Dallas-based startup that provides secure edge computing resources.
MORE►
by Lance Murray |
Jan 15, 2020
Regardless of what type of funding it is—seed, venture capital, angel, or corporate—here are 31 North Texas companies that successfully pulled in capital last year to back their ventures.
MORE►
Image: Valery Brozhinsky/iStockPhoto
Fort Worth Biotech Eyevensys Completes $30M Series B Funding Round
by Lance Murray | Jan 8, 2020
The startup plans to use the funding to continue developing its technology and to position it as an innovator in ophthalmology. Eyevensys’ tech is a gene therapy platform to deliver ocular drugs via an electrotransfection system to the ciliary muscle of the eye.
MORE►
by Lance Murray |
Jan 7, 2020
The funding will accelerate the national distribution of Pieces’ clinical analytics engine and social determinants of health platform.
MORE►
by Lance Murray |
Nov 29, 2019
In this weekly roundup of funding, mergers, and acquisition activity involving companies with North Texas ties, you’ll also find news from Automation Anywhere, Maverick Capital, Charles Schwab, TD Ameritrade, SpotSee, and Novaria Group.
MORE►
by Lance Murray |
Nov 14, 2019
In this weekly roundup of funding, merger, and acquisition activity involving companies with North Texas ties, you’ll also find news from Kanarys, Sweat Equities, RSF Partners, Siemens, GoPlant and Align Midstream Partners.
MORE►
